You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
People
GXO appointed to manage NHS England bowel cancer home testing kits
Login
Username:

Password:


Related Headlines

GelMEDIX completes USD13m seed financing, announces first partnership

AmacaThera named Life Sciences Ontario Emerging Company of the Year

GenSight Biologics reports first patient treated in GS010 REVISE study

Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme

OncoHost receives BIG Innovation Award in Health category

Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US

MemorialCare hospitals recognised in 2026 Women's Choice Awards

Champions Oncology expands bioanalytical services with new technology and leadership

Kedrion's investigational treatment for Congenital Aceruloplasminemia receives European Orphan Drug Designation

PhaseV receives three industry honours for AI in clinical development

Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation

Galapagos plans to wind down cell therapy business following strategic review

Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025

Revelation Pharma acquires Acacia Apothecary & Wellness

Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026